HomeHealthFDA Issues DO NOT USE Warning For Unauthorized Covid-19 Rapid Test, False...

FDA Issues DO NOT USE Warning For Unauthorized Covid-19 Rapid Test, False Results

Published on

spot_img

The U.S. Food and Drug Administration on Tuesday issued a “do not use” warning about the Skippack Medical Lab SARS-CoV-2 Antigen Rapid Test (Colloidal Gold) because it “is not authorized, cleared, or approved by the FDA for distribution or use in the United States.”

The FDA said it is concerned about the risk of receiving false results because the company, SML Distribution LLC, “has not provided the FDA with adequate data to show the test works correctly.”

SML Distribution, the FDA said, has recalled the tests.

The test uses a nasal swab to detect the proteins from the virus that causes COVID-19.

SML Distribution, based in Tyrone, Pa., recalled up to 209,450 of the tests on March 4. They were distributed in the United States from Jan. 21, 2022, to Feb. 11, 2022.

For more information, call SML Distribution at 888-209-4406 or send an email to techsupport@smldistribution.com.

The FDA has previously issued warnings about other COVID-19 tests it has not authorized.

- Advertisement -

Latest articles

Get The Daily Email!

Matt Clark On Demand

More like this

JUST IN: Adam Schiff Hit With Ethics Complaint Just One Day After Announcing Senate Run

Just one day after announcing his 2024 Senate run, far-left radical and disgraced House Rep. Adam Schiff (R-CA) was hit with an ethics complaint.

Rep. Matt Gaetz Introduces PENCIL Act to Prevent Adam Schiff From Ever Seeing Classified Info

Matt Gaetz introduced the PENCIL Act; inspired by former President Donald Trump’s nickname for the California Rep: “Pencil-Neck.”

Hawley Introduces PELOSI Act To Bar Lawmakers From Trading Stocks While In Office

Hawley introduced the PELOSI ACT that requires members and their spouses from making millions off insider trading.